|
1
|
Sulciner ML, Serhan CN, Gilligan MM, Mudge
DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli
J, et al: Resolvins suppress tumor growth and enhance cancer
therapy. J Exp Med. 215:115–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ragin CC and Taioli E: Survival of
squamous cell carcinoma of the head and neck in relation to human
papillomavirus infection: Review and meta-analysis. Int J Cancer.
121:1813–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang SY, Lu ZM, Luo XN, Chen LS, Ge PJ,
Song XH, Chen SH and Wu YL: Retrospective analysis of prognostic
factors in 205 patients with laryngeal squamous cell carcinoma who
underwent surgical treatment. PLoS One. 8:e601572013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markou K, Goudakos J, Triaridis S,
Konstantinidis J, Vital V and Nikolaou A: The role of tumor size
and patient's age as prognostic factors in laryngeal cancer.
Hippokratia. 15:75–80. 2011.PubMed/NCBI
|
|
6
|
Moreno F, Vega M and Herrero P: The
nuclear Hexokinase 2 acts as a glucose sensor in Saccharomyces
cerevisiae. J Biol Chem. 291:164782016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anderson M, Marayati R, Moffitt R and Yeh
JJ: Hexokinase 2 promotes tumor growth and metastasis by regulating
lactate production in pancreatic cancer. Oncotarget. 8:56081–56094.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Xiong H, Wu F, Zhang Y, Wang J,
Zhao L, Guo X, Chang LJ, Zhang Y, You MJ, et al: Hexokinase
2-mediated Warburg effect is required for PTEN-and
p53-deficiency-driven prostate cancer growth. Cell Rep.
8:1461–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Zhang S, Li Y, Tang Z and Kong W:
Hexokinase 2 overexpression promotes the proliferation and survival
of laryngeal squamous cell carcinoma. Tumour Biol. 35:3743–3753.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mathupala SP, Ko YH and Pedersen PL:
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the
‘Warburg Effect’ and a pivotal target for effective therapy. Semin
Cancer Biol. 19:17–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tong YS, Zhou XL, Wang XW, Wu QQ, Yang TX,
Lv J, Yang JS, Zhu B and Cao XF: Association of decreased
expression of long non-coding RNA LOC285194 with chemoradiotherapy
resistance and poor prognosis in esophageal squamous cell
carcinoma. J Transl Med. 12:2332014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding YC, Yu W, Ma C, Wang Q, Huang CS and
Huang T: Expression of long non-coding RNA LOC285194 and its
prognostic significance in human pancreatic ductal adenocarcinoma.
Int J Clin Exp Pathol. 7:8065–8070. 2014.PubMed/NCBI
|
|
16
|
Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C,
Zhou XY and Du X: Low expression of LOC285194 is associated with
poor prognosis in colorectal cancer. J Transl Med. 11:1222013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shaw RJ: Glucose metabolism and cancer.
Curr Opin Cell Biol. 18:598–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wolf A, Agnihotri S, Micallef J, Mukherjee
J, Sabha N, Cairns R, Hawkins C and Guha A: Hexokinase 2 is a key
mediator of aerobic glycolysis and promotes tumor growth in human
glioblastoma multiforme. J Exp Med. 208:313–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Liu Y and Xu X: Knockdown of
LncRNA-UCA1 suppresses chemoresistance of pediatric AML by
inhibiting glycolysis through the microRNA-125a/hexokinase 2
pathway. J Cell Biochem. 119:6296–6308. 2018. View Article : Google Scholar : PubMed/NCBI
|
